Synthetic Biologics Inc (SYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYN | AMGN | VRTX | REGN | BMY |
| Company | Synthetic Biologics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.0200 | 313.39 | 401.50 | 926.94 | 43.90 |
| High | 1.0200 | 322.60 | 405.67 | 947.08 | 44.25 |
| Low | 0.9700 | 310.65 | 400.59 | 926.94 | 43.81 |
| Last | 1.0200 | 314.95 | 400.43 | 940.31 | 44.23 |
| Change | +0.0100 | +36.56 | +0.27 | +2.70 | +0.53 |
| % Change | +0.99% | +13.13% | +0.07% | +0.29% | +1.21% |
| Volume | 57,700 | 2,996,076 | 89,995 | 37,510 | 1,251,142 |
| 20-Day Average Volume | 49,125 | 2,274,679 | 970,765 | 492,033 | 13,892,517 |
| Previous Close | 1.0100 | 278.39 | 400.16 | 937.61 | 43.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1113 | 272.43 | 398.64 | 909.22 | 47.47 |
| 20-Day Raw Stochastic | 11.63% | 87.05% | 89.46% | 92.90% | 8.77% |
| 20-Day Relative Strength | 34.20% | 73.17% | 50.46% | 55.90% | 29.70% |
| Weighted Alpha | -82.00 | +35.63 | +16.01 | +24.36 | -36.52 |
| Today's Opinion | 100% Sell | 24% Buy | 8% Buy | 64% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 16% Sell | 8% Buy | 48% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 24% Sell | 24% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.30% since 10/05/22 | +16.52% since 04/26/24 | +1.96% since 04/26/24 | +6.88% since 04/26/24 | -1.75% since 04/26/24 |
| Low | 0.9700 on 10/12/22 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 883.20 on 04/29/24 | 43.33 on 05/02/24 |
| High | 1.1900 on 10/06/22 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 945.86 on 05/03/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | -28.17% since 09/12/22 | +14.63% since 04/03/24 | -0.87% since 04/03/24 | -0.74% since 04/03/24 | -15.55% since 04/03/24 |
| Low | 0.9700 on 10/12/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.4700 on 09/13/22 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 962.20 on 04/04/24 | 52.08 on 04/04/24 |
| 3-Month | |||||
| %Chg | -57.07% since 07/12/22 | -2.66% since 02/02/24 | -4.57% since 02/02/24 | -0.13% since 02/02/24 | -9.54% since 02/02/24 |
| Low | 0.9700 on 10/12/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 2.3990 on 07/13/22 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -60.90% since 04/12/22 | +16.57% since 11/03/23 | +7.73% since 11/03/23 | +15.55% since 11/03/23 | -16.58% since 11/03/23 |
| Low | 0.9700 on 10/12/22 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 2.6900 on 04/13/22 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,161 | 149,321,728 | 103,424,960 | 102,913,952 | 88,584,272 |
| Shares Outstanding, K | 15,844 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -14,270,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -4,968,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.38 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 08/11/22 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 11/02/22 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 24.04 | 42.10 |